home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

271 rows where filing_period = "third_quarter", filing_year = 2017 and issue_code = "MED" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, income_amount, is_termination, received_date (date)

issue_code 1

  • MED · 271 ✖

filing_year 1

  • 2017 · 271 ✖

filing_period 1

  • third_quarter · 271 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
2018941 WEBMD HEALTH CORP. 843fa214-fa1e-4f7e-80b4-65162c000f2b 3T WEBMD HEALTH CORP. 55473 WEBMD HEALTH CORP 2017 third_quarter MED Explore partnership opportunities with the government to disseminate healthcare and research information to physicians and consumers. Federal health care reform efforts; Privacy, security and confidentiality issues; Direct to consumer advertising; Wellness programs and incentives for creation of such programs; Pharma issues related to both advertising and deduction of expenses associated with advertising; Personal health records. HOUSE OF REPRESENTATIVES,SENATE   10000 0 1 2017-09-28T11:35:31.400000-04:00
2019053 MARSHALL BRACHMAN 829950ed-7a30-40aa-aef0-801ff826ee61 Q3 MARSHALL BRACHMAN 6848 BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM 2017 third_quarter MED support funding for medical research programs HOUSE OF REPRESENTATIVES,SENATE 33000   0 0 2017-10-01T10:45:17.847000-04:00
2019285 NATURAL RESOURCE RESULTS LLC 48f02549-4ad6-461e-b5ad-9d10385aa110 Q3 NATURAL RESOURCE RESULTS LLC 321555 SHINE MEDICAL TECHNOLOGIES 2017 third_quarter MED Support lifting cap on NNSA program for medical isotope production under AMIPA; support funding SHINE facility under same program at NNSA in FY18 approps and FY19 budget. Council on Environmental Quality (CEQ),Energy, Dept of,HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),Office of Management & Budget (OMB),SENATE,White House Office 10000   0 0 2017-10-03T05:43:49.930000-04:00
2019426 THE FRIEDLANDER GROUP 92e49637-697a-4f7d-8790-a47bb7494472 Q3 THE FRIEDLANDER GROUP 400535604 OHEL CHILDRENS HOME AND FAMILY SERVICES 2017 third_quarter MED Block Grants HOUSE OF REPRESENTATIVES,SENATE     0 0 2017-10-03T12:43:45.003000-04:00
2019597 AMERICAN COLLEGE OF CLINICAL PHARMACY 90ddca98-51a5-4825-bc66-f73876dde068 Q3 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2017 third_quarter MED Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   128375 0 0 2017-10-04T09:57:51.917000-04:00
2019614 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 0f758f71-cb06-49ec-b9ec-015215205ffb Q3 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 400361684 VIJUK EQUIPMENT, INC. 2017 third_quarter MED Pharmaceutical labeling Food & Drug Administration (FDA) 18750   0 0 2017-10-04T10:54:09.323000-04:00
2019708 FEDERAL SOLUTIONS, LLC 9f60a571-4cf3-4a24-b54e-e665afcc7d8f Q3 FEDERAL SOLUTIONS, LLC 311371 MISSISSIPPI STATE UNIVERSITY 2017 third_quarter MED Labor/HHS/Education Appropriation Bill: Provisions relating to disease research. Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),SENATE 50000   0 0 2017-10-04T14:14:24.157000-04:00
2019717 FEDERAL SOLUTIONS, LLC a1d986da-b5ec-4cf8-8e0f-408a354b7a08 Q3 FEDERAL SOLUTIONS, LLC 311371 JACKSONVILLE STATE UNIVERSITY 2017 third_quarter MED Labor/HHS/Education Appropriations Bill: Provisions relating to disease research, education and development. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2017-10-04T14:16:28.327000-04:00
2019785 GRIZZLE COMPANY 33d112df-3bcd-450b-b723-355be0a7d488 Q3 GRIZZLE COMPANY 16987 UNIVERSITY OF LOUISVILLE 2017 third_quarter MED Request letters of support for a grant application to the NIH. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2017-10-04T15:31:09.197000-04:00
2019907 O'NEILL AND ASSOCIATES f3baf852-d127-49ab-902d-586a7698e821 Q3 O'NEILL AND ASSOCIATES 73134 POINT32HEALTH SERVICES, INC. (FORMERLY TUFTS HEALTH PLAN) 2017 third_quarter MED Medicare advantage and health care reform HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2017-10-05T11:30:36.710000-04:00
2020158 RAY C CULVER III a99b6d22-13ad-405c-bcde-fc568d9c406a Q3 RAY C CULVER III 11468 ARKANSAS CHILDREN'S HOSPITAL 2017 third_quarter MED Funding for the USDA Agricultural Research Service human nutrition research centers in the FY18 Agricultural Appropriations bill and CR (currently HR 3354 and PL 115-56). HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2017-10-05T22:14:23.870000-04:00
2020271 ALZHEIMER'S FOUNDATION OF AMERICA 622a9b39-025a-49af-9a7e-ab75e5a7a7ba Q3 ALZHEIMER'S FOUNDATION OF AMERICA 323158 ALZHEIMER'S FOUNDATION OF AMERICA 2017 third_quarter MED S. 445 - the Home Health Care Planning Improvement Act of 2017 S. 464 - Independence at Home Act of 2017 H.R. 1825, Home Health Care Planning Act Senate Finance CHRONIC Act Administration on Aging,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office   30000 0 0 2017-10-06T10:28:32.623000-04:00
2020283 AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY bc92c36d-0bb7-405e-993b-f0fe36524bdc Q3 AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY 3344 AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY 2017 third_quarter MED biomedical research HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE 50000   0 0 2017-10-06T10:34:42.620000-04:00
2020304 PARRY, ROMANI, DECONCINI & SYMMS e7014bd4-4df9-4b4b-95b2-0096f3b54ca4 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 AIDS HEALTHCARE FOUNDATION 2017 third_quarter MED Department of Labor, Health, Human Services, and Education, and Related Agencies Appropriations Act, FY 2018 - Support funding for medical treatments for HIV positive patients. Support appropriate funding for the ADAP program. HOUSE OF REPRESENTATIVES,SENATE 36000   0 0 2017-10-06T11:01:08.300000-04:00
2020541 TCH GROUP, LLC 62e11b31-a7c5-4e29-b0e6-2cc910bf6f77 Q3 TCH GROUP, LLC 51478 INTERNATIONAL AIDS VACCINE INITIATIVE 2017 third_quarter MED FY 18 Omnibus Appropriations bill (HR 3354), FY 18 CR (HR 601), FY 18 House and Senate State Foreign Operations Subcommittee Appropriations bills (HR 3362 and S 1780). Specifically, continued Federal funding under USAID for AIDS vaccine research and development HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2017-10-07T12:31:05.957000-04:00
2020925 HOLLAND & KNIGHT LLP 74e70921-0b55-4f83-8721-7cad75d3ff48 Q3 HOLLAND & KNIGHT LLP 18466 THE BIOSIMILARS FORUM 2017 third_quarter MED Medicare reimbursement issues, FDA regulation of biosimilars; S. 934, H.R. 2430, the FDA Reauthorization Act of 2017. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 120000   0 0 2017-10-09T15:40:15.367000-04:00
2021128 LNE GROUP 740bd325-7222-4eb6-ba79-344757a9eba9 Q3 LNE GROUP 308811 HOSPICE OF THE WESTERN RESERVE 2017 third_quarter MED Lobbied on issues related to medical/disease research. HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) 30000   0 0 2017-10-10T11:00:40.497000-04:00
2021190 LNE GROUP 0035e7a7-6285-4c71-915c-a66bca095a99 Q3 LNE GROUP 308811 PARKER HANNIFIN 2017 third_quarter MED Lobbied for issues related to medical research. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2017-10-10T11:32:38.003000-04:00
2021288 SI-BONE, INC. 96a5de1f-b959-496e-ac2f-9e354c7107a6 Q3 SI-BONE, INC. 401104473 SI-BONE, INC. 2017 third_quarter MED Reimbursement coverage for certain covered medical device procedures Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   80864 0 0 2017-10-10T12:34:09.797000-04:00
2021460 RUSSELL PUBLIC COMMUNICATIONS ce47f029-d4e3-4b6b-9f52-4c1b2c1ef15a Q3 RUSSELL PUBLIC COMMUNICATIONS 401104398 ACCELERATE DIAGNOSTICS, INC. 2017 third_quarter MED Advocated for support of antibiotic resistance research and use of appropriate rapid diagnostic technology HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2017-10-10T14:53:25.370000-04:00
2021504 KASOWITZ LLP f7a8e950-3cf5-47f0-b41f-9c120b61aa46 Q3 KASOWITZ LLP 401103221 SPECTRUM PHARMACEUTICALS 2017 third_quarter MED Regulation of the medical use of nuclear materials and its effect on cancer patient access.       0 0 2017-10-10T15:52:15.867000-04:00
2021582 MCDERMOTT+ LLC ab6da4a0-eff2-4357-8080-c75e7a0e2bba Q3 MCDERMOTT+ LLC 401103287 COALITION FOR 21ST CENTURY MEDICINE 2017 third_quarter MED Issues concerning regulation of laboratory-developed tests. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 80000   0 0 2017-10-10T16:43:58.350000-04:00
2021658 WAKE FOREST UNIVERSITY HEALTH SCIENCES 77834c4d-49fe-4282-af20-ca9b7f0e4d43 Q3 WAKE FOREST UNIVERSITY HEALTH SCIENCES 6781 WAKE FOREST UNIVERSITY HEALTH SCIENCES 2017 third_quarter MED VA Research funding Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   130000 0 0 2017-10-11T09:04:59.657000-04:00
2022077 PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION d5c2d3d1-e994-40a9-af26-910047b15ca6 Q3 PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION 401103605 PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION 2017 third_quarter MED Lobbied for timely passage of FDA Reauthorization Act (H.R. 2430, S. 934), for changes to proposed OTC Monograph Safety, Innovation and Reform Act of 2017, and for potential solutions to drug shortage situations, and provided general education about the pharma/biopharma contract services sector. HOUSE OF REPRESENTATIVES,SENATE   60000 0 0 2017-10-11T14:21:46.893000-04:00
2022375 NELSON MULLINS RILEY & SCARBOROUGH f6d0a348-c5a4-44dd-89f9-f0e77954f3fc Q3 NELSON MULLINS RILEY & SCARBOROUGH 285871 NATERA, INC. 2017 third_quarter MED Biomedical research, maternal health, and genetic testing HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2017-10-12T09:37:10.360000-04:00
2022418 CORNERSTONE GOVERNMENT AFFAIRS, INC. b5d88fd8-2655-4bf2-89d2-65645c466ca6 Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 OPERATION SPEC-OPS ADVANCE FOUNDATION 2017 third_quarter MED Educate policymakers, defense committees, defense community, industry and veterans community on the client. Secure funding for education and placement of special operations service members accepted into client's program Defense, Dept of (DOD),Veterans Affairs, Dept of (VA) 10000   0 0 2017-10-12T10:17:06.850000-04:00
2022783 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 9ea8f844-3e09-47e1-958b-d27bca912f7a Q3 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 312496 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 2017 third_quarter MED NIH funding HHS budget bill, PREA re-authorization, cancer moonshot Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   58708 0 0 2017-10-12T14:12:43.850000-04:00
2022810 POYNER SPRUILL LLP 2edc5a95-2b9d-46fe-ae30-9d403e699e5a Q3 POYNER SPRUILL LLP 400563685 AMERICAN COLLEGE OF SPORTS MEDICINE, INC. 2017 third_quarter MED vital role of physical activity and sports, fitness (including the President's Council on Physical Fitness, Nutrition and Sports), worksite wellness activities, disease prevention through healthy lifestyles, promotion of good health and diet, funding for Labor, HHS and Education Appropriation Bills, concussion legislation, good nutrition and infrastructure initiatives for pedestrians and cyclists and other health-related matters. HOUSE OF REPRESENTATIVES,SENATE     0 0 2017-10-12T14:27:02.097000-04:00
2022831 INTUITIVE SURGICAL, INC. 6af0a834-0254-48c1-89f4-33cced960997 Q3 INTUITIVE SURGICAL, INC. 400670004 INTUITIVE SURGICAL, INC. 2017 third_quarter MED comparative effectiveness research in healthcare Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   40000 0 0 2017-10-12T14:41:20.093000-04:00
2023555 JEFFREY J. KIMBELL & ASSOCIATES, INC. 098bd1ab-92a6-4df1-b688-cdb5547cb779 Q3 JEFFREY J. KIMBELL & ASSOCIATES, INC. 46038 SANTHERA PHARMACEUTICALS (USA), INC. 2017 third_quarter MED Issues related to development of treatments for rare diseases. HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2017-10-13T13:23:51.863000-04:00
2023576 JEFFREY J. KIMBELL & ASSOCIATES, INC. d7075696-c2ba-4d3f-969f-a456fd1a84a3 Q3 JEFFREY J. KIMBELL & ASSOCIATES, INC. 46038 FUJIREBIO DIAGNOSTICS, INC. 2017 third_quarter MED Issues related to medical devices and lab developed tests. HOUSE OF REPRESENTATIVES,SENATE     0 0 2017-10-13T13:35:08.297000-04:00
2023634 MARSHFIELD CLINIC HEALTH SYSTEM 7a8893d0-342d-449f-85b6-20d7e2a32234 Q3 MARSHFIELD CLINIC HEALTH SYSTEM 57830 MARSHFIELD CLINIC HEALTH SYSTEM 2017 third_quarter MED Protecting Access to Medicare Act of 2014 (PAMA) PAMA includes reforms to the Clinical Lab Fee Schedule (CLFS). This rule for PAMA requires reporting of Clinical lab prices and volumes. MCHS requested a delay in the reporting, and changes to expand the definition of applicable lab to represent the true market of all laboratories; requested greater transparency of calculations; more time to allow for gathering data and implementation. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)   100000 0 0 2017-10-13T14:10:42.740000-04:00
2024045 K&L GATES, LLP b353a5cf-75c9-4bcc-b840-aad5733a4627 Q3 K&L GATES, LLP 32098 VGM GROUP, INC. D/B/A VGM & ASSOCIATES 2017 third_quarter MED BREATH Act, all provisions (not yet introduced). HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2017-10-14T11:46:46.457000-04:00
2024120 BROYDRICK & ASSOCIATES 9eb95cab-2ee6-42e9-b1fe-e1c204e17452 Q3 BROYDRICK & ASSOCIATES 7268 EXACT SCIENCES 2017 third_quarter MED Legislation on cancer screening test process. Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2017-10-15T13:20:10.460000-04:00
2024129 BROYDRICK & ASSOCIATES 729b140d-93ca-4c40-8dc3-d1a3b58d3cfd Q3 BROYDRICK & ASSOCIATES 7268 NORTHSTAR RADIOISOTOPES, LLC 2017 third_quarter MED DOE policies and cooperative agreements expansion legislation. Nuclear medicine and CMS Reimbursement. NNSA reorganization, S512 Uranium production (2017). DOE appropriations. Energy, Dept of,HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2017-10-15T13:28:19.507000-04:00
2024145 FRANCIS EDWARD & CRONIN, INC. 1511b1d4-a398-4663-be92-2719a9f63ea6 Q3 FRANCIS EDWARD & CRONIN, INC. 311314 CURE ALZHEIMER'S FUND 2017 third_quarter MED Legislation related to Alzheimer's disease research. HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2017-10-15T19:02:39.823000-04:00
2024146 FRANCIS EDWARD & CRONIN, INC. f9c2e380-06ca-4d6a-9a01-1fb9376cf079 Q3 FRANCIS EDWARD & CRONIN, INC. 311314 PATH DECISION SUPPORT SOFTWARE, LLC 2017 third_quarter MED Issues and legislation related to diabetes diagnosis and treatment. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE     0 0 2017-10-15T19:04:41.263000-04:00
2024208 SRI INTERNATIONAL 5bed74bb-f85a-4a72-93ff-3db7e8d68b22 Q3 SRI INTERNATIONAL 90990 SRI INTERNATIONAL 2017 third_quarter MED FY18 Labor-HHS-Education Appropriations HOUSE OF REPRESENTATIVES,SENATE   8000 0 0 2017-10-16T09:24:42.903000-04:00
2024280 THE PETRIZZO GROUP, INC. a8cc5f9f-dd19-4ee2-94b6-238eba7c4c0b Q3 THE PETRIZZO GROUP, INC. 305932 FRED HUTCHINSON CANCER RESEARCH CENTER 2017 third_quarter MED Advocated for increased funding for NIH and NCI. Advocated for precision medicine and precision oncology issues. Advocated for clinical research administrative reforms. Advocated against any reductions to indirect cost reimbursement rates provided by NIH. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2017-10-16T09:54:32.710000-04:00
2024287 MCDERMOTT WILL & SCHULTE LLP 6ee1eb0d-5629-413b-8a17-df3ca686cda2 Q3 MCDERMOTT WILL & SCHULTE LLP 24338 MAYO CLINIC 2017 third_quarter MED Issues impacting academic medical centers. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2017-10-16T09:55:37.693000-04:00
2024288 THE PETRIZZO GROUP, INC. 20d6b709-4254-4612-b2a0-e8ef7d23965d Q3 THE PETRIZZO GROUP, INC. 305932 ALLEN INSTITUTE 2017 third_quarter MED Advocated for funding of the BRAIN Initiative and full funding for NIH. Advocated for the development of open data hosting, and integrated, scalable data analysis hubs for the BRAIN Initiative at NIH. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2017-10-16T09:56:38.773000-04:00
2024308 THE PETRIZZO GROUP, INC. 7924776c-e243-4aaa-85dc-7b91ceefb551 Q3 THE PETRIZZO GROUP, INC. 305932 OMEROS CORPORATION 2017 third_quarter MED Advocated for Medicare Part B packaged payment reform. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2017-10-16T10:06:50.773000-04:00
2024372 PARALYZED VETERANS OF AMERICA 1c0b71d2-9b3a-42db-b7d9-560b15956c2f Q3 PARALYZED VETERANS OF AMERICA 30724 PARALYZED VETERANS OF AMERICA 2017 third_quarter MED Department of Veterans Affairs, Medical Research Issues National Institutes of Health, Medical Research Issues HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)   82862 0 0 2017-10-16T10:32:25.200000-04:00
2024428 ALEXION PHARMACEUTICALS, INC. fabd86e4-9813-48db-9dd9-61b98260b3b8 Q3 ALEXION PHARMACEUTICALS, INC. 400504482 ALEXION PHARMACEUTICALS, INC. 2017 third_quarter MED PDUFA Reauthorization Right-to-Try Legislation RACE for Children Act HOUSE OF REPRESENTATIVES,SENATE   275000 0 0 2017-10-16T10:46:55.497000-04:00
2024916 HANCE SCARBOROUGH bd64049a-a917-416d-9b1b-d7e3fd73259a Q3 HANCE SCARBOROUGH 17443 TEXAS ALLIANCE FOR PATIENT ACCESS 2017 third_quarter MED Issues related to federal malpractice legislation. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2017-10-16T13:30:21.937000-04:00
2024945 HANCE SCARBOROUGH 71d3caf7-1db2-4a11-90d9-4858bb81f35f 3T HANCE SCARBOROUGH 17443 TEXAS ALLIANCE FOR PATIENT ACCESS 2017 third_quarter MED Issues related to federal malpractice legislation. HOUSE OF REPRESENTATIVES,SENATE 10000   0 1 2017-10-16T13:34:38.407000-04:00
2024966 THE O TEAM LLC b0fd48cf-d920-4c6a-9eca-1ad0de22facc Q3 THE O TEAM LLC 400783359 THE SUZANNE WRIGHT FOUNDATION 2017 third_quarter MED Pancreatic cancer awareness. HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2017-10-16T13:41:51.440000-04:00
2025120 WILLIAMS AND JENSEN, PLLC 5d553d37-5b93-47f1-8a3e-9a49756b8dda Q3 WILLIAMS AND JENSEN, PLLC 41454 GLOBAL DOWN SYNDROME FOUNDATION 2017 third_quarter MED Support for down syndrome research funding. HOUSE OF REPRESENTATIVES,SENATE     0 0 2017-10-16T14:11:27.163000-04:00
2025160 LUCY CALAUTTI 1c8f05c9-e3b8-44aa-96cd-cab49cbd0a97 Q3 LUCY CALAUTTI 401104011 CHILDREN'S HOSPITAL ASSOCIATION 2017 third_quarter MED Repeal and replace Affordable Care Act legislation; Medicaid funding; per capita caps in Medicaid. Children's Health Insurance Program.   30000   0 0 2017-10-16T14:16:51.460000-04:00
2025316 WINNING STRATEGIES WASHINGTON 2290011e-b827-458d-9cb3-43154aee7061 Q3 WINNING STRATEGIES WASHINGTON 50796 HEALTHCARE INSTITUTE OF NEW JERSEY 2017 third_quarter MED Monitor Prescription Drug User Fee Act re-authorization HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2017-10-16T14:36:31.363000-04:00
2025526 WINNING STRATEGIES WASHINGTON 21ecb2bf-1e22-40d7-ad7a-eb9d0bb4528e Q3 WINNING STRATEGIES WASHINGTON 50796 LAHEY HEALTH 2017 third_quarter MED Rural wage index Medicare Reform HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2017-10-16T15:01:28.287000-04:00
2025530 WILLIAMS AND JENSEN, PLLC 8f6b90cc-de2d-4c17-b0bc-22732573b0f8 Q3 WILLIAMS AND JENSEN, PLLC 41454 BIOGEN IDEC 2017 third_quarter MED Prescription drug user fee agreements and general education about FDA approval polices and NIH research activities. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2017-10-16T15:02:30.897000-04:00
2025540 WILLIAMS AND JENSEN, PLLC b41895eb-89e8-4629-b767-63cb5b9ff315 Q3 WILLIAMS AND JENSEN, PLLC 41454 SANOFI, U.S. 2017 third_quarter MED General education about FDA approval policies and NIH research activities. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2017-10-16T15:03:36.787000-04:00
2025625 WILLIAMS AND JENSEN, PLLC b04d276c-593d-42c5-8629-57516a8e7f19 Q3 WILLIAMS AND JENSEN, PLLC 41454 VERTEX PHARMACEUTICALS INCORPORATED 2017 third_quarter MED Prescription drug user fee agreements and general education about FDA approval policies and NIH research activities. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2017-10-16T15:20:26.383000-04:00
2025641 FORBES-TATE 41e74fca-ae3f-4037-a97b-d8d821761e27 Q3 FORBES-TATE 400976792 GENENTECH 2017 third_quarter MED Issues related to Right to Try. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2017-10-16T15:25:33.757000-04:00
2025784 FORBES-TATE 7cd416c6-e379-447b-b4d5-09d1c695829d Q3 FORBES-TATE 400976792 PHRMA 2017 third_quarter MED Issues related to "Right to Try" legislation. HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2017-10-16T16:03:57.480000-04:00
2025979 THE PAUL LAXALT GROUP 8b573a16-b7d6-49b4-9a6c-3e670b950143 Q3 THE PAUL LAXALT GROUP 22325 THE ROGOSIN INSTITUTE 2017 third_quarter MED Monitor issues concerning improvements in medical research and treatment of kidney disease. Creating High-Quality Results and Outcomes Necessary to Improve Chronic Care Act of 2017 - S. 870 HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2017-10-16T17:04:30.987000-04:00
2026274 CAPITOL HILL STRATEGIES, LLC 0cd56006-ee6e-4012-914e-8ac9157a1da4 Q3 CAPITOL HILL STRATEGIES, LLC 91774 BIOTECHNOLOGY INDUSTRY ORGANIZATION 2017 third_quarter MED H.R. 2430, the FDA Reauthorization Act (FDARA) of 2017, legislation to reauthorize the Prescription Drug User Fee Act (PDUFA), as reauthorized by the Food and Drug Administration Safety and Innovation Act of 2012 (FDASIA). HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2017-10-17T09:30:04.430000-04:00
2026541 SIDLEY AUSTIN LLP be1b8fe8-9847-4cf0-99db-7da7ee807b1a Q3 SIDLEY AUSTIN LLP 35230 CORD BLOOD ASSOCIATION 2017 third_quarter MED Legislative and Federal agency activities related to H.R.2820 (Health Equity Act of 2013) and the Stem Cell Therapeutic and Research Reauthorization Act of 2015 Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA) 10000   0 0 2017-10-17T10:43:14.643000-04:00
2026729 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8562264c-f7d7-49cc-895b-8648714f5d5d Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 TUBEROUS SCLEROSIS ALLIANCE 2017 third_quarter MED HR 3358/HR 3354/S 1771, FY 2018, Labor-HHS-Education Appropriations bill, Tuberous Sclerosis, research at the National Institutes of Health and the Centers for Disease Control and Prevention. HR 3219/ HR 3354, FY 2018 Defense Appropriations Act, Tuberous Sclerosis Medical Research program HR 2810/S 1519, National Defense Authorization Act, DoD medical research programs HR 1628, Better Care Reconciliation Act HR 1628, American Health Care Act HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2017-10-17T11:35:14.007000-04:00
2026784 FAEGRE DRINKER BIDDLE & REATH LLP 16f55116-33ab-4e3b-a62f-e07e3385b075 Q3 FAEGRE DRINKER BIDDLE & REATH LLP 12631 AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE 2017 third_quarter MED Public Health Programs for Infectious and Tropical Disease; NIH Research; Issues related to government agency conference travel; malaria and NDT caucus membership. Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,U.S. Agency for International Development (USAID) 30000   0 0 2017-10-17T11:50:36.227000-04:00
2026910 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. cecc85f0-5bd1-43e5-bed4-fdbc11083918 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ENDOCRINE SOCIETY 2017 third_quarter MED Research in Endocrinology Centers For Medicare and Medicaid Services (CMS),Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2017-10-17T12:17:59.827000-04:00
2026967 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 9184bfaa-bad0-41e7-be6e-0ea08e890501 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION 2017 third_quarter MED Research opportunities at the Department of Defense and the Centers for Disease Control. HR 3358/ HR 3354/ S 1771, FY 2018, Labor-HHS Appropriations Act, blood and bleeding disorders. HR 3219/HR 3354, FY 18 Defense Appropriations Act, defense medical research HR 2810/ S 1519, National Defense Authorization Act, DoD medical research programs HR 1628, Better Care Reconciliation Act HR 1628, American Health Care Act HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2017-10-17T12:26:31.280000-04:00
2026971 PALMETTO GROUP 0c76beb4-ceb0-480f-b88b-d4e16082b541 Q3 PALMETTO GROUP 18570 INTERNATIONAL AIDS VACCINE INITIATIVE 2017 third_quarter MED Federal Funding of AIDS vaccine Department of State, Foreign Operations, and Related Programs Appropriations Act HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2017-10-17T12:27:33.607000-04:00
2027141 SQUIRE PATTON BOGGS 5d82f507-01a0-4532-b299-b1bda6f35820 Q3 SQUIRE PATTON BOGGS 30906 ALLIANCE FOR BIOSECURITY 2017 third_quarter MED Preparedness and response as it relates to Biosecurity. Health & Human Services, Dept of (HHS) 80000   0 0 2017-10-17T13:21:27.193000-04:00
2027159 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. e1bbb22f-a9f7-40d8-b360-fa3d2fdf504f Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 AMERICAN BRAIN TUMOR ASSOCIATION 2017 third_quarter MED HR 3219/ HR 3354, FY 18 Defense Appropriations Act, defense medical research programs HR 3358/HR 3354/S 1771, Labor-HHS, cancer research HR 1628, American Health Care Act HR 1628, Better Care Reconciliation Act HR 2810/ S 1519, National Defense Authorization Act, DoD medical research programs Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2017-10-17T13:25:40.660000-04:00
2027210 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 55a5ade0-8186-4f9f-a374-46d05436fd84 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 AMERICAN SOCIETY OF HEMATOLOGY 2017 third_quarter MED Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease; HR 2410 SCD Research, Surveillance Prevention and Treatment Act of 2017 Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2017-10-17T13:35:10.350000-04:00
2027226 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 2a84c594-b784-4943-8bc2-55f056ffd52f Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL ASSOCIATION OF EPILEPSY CENTERS 2017 third_quarter MED Research and public health programs in epilepsy. Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2017-10-17T13:36:14.210000-04:00
2027250 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. ba5a919f-80ec-4165-8b60-9ed9add90b7a Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL HEMOPHILIA FOUNDATION 2017 third_quarter MED Hemophilia research, prevention, surveillance and service programs and issues. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 50000   0 0 2017-10-17T13:40:24.837000-04:00
2027287 HOGAN LOVELLS US LLP 2f132932-0c8f-48ff-a56c-3ea475d58dd0 Q3 HOGAN LOVELLS US LLP 18422 COALITION FOR CELL BIOLOGY 2017 third_quarter MED Issues relating to the federal funding of biomedical research. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2017-10-17T13:46:43.147000-04:00
2027425 FAEGRE DRINKER BIDDLE & REATH LLP 35694329-756a-4b3b-9f13-13d87e074f6b Q3 FAEGRE DRINKER BIDDLE & REATH LLP 12631 DRUGS FOR NEGLECTED DISEASES INITIATIVE OF NORTH AMERICA 2017 third_quarter MED Issues related to priority review voucher for tropical diseases. HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 10000   0 0 2017-10-17T14:23:13.060000-04:00
2027503 SQUIRE PATTON BOGGS 881a25ba-4f68-4252-9f0b-3eb5990f60d7 Q3 SQUIRE PATTON BOGGS 30906 MOLNLYCKE HEALTH CARE US, LLC 2017 third_quarter MED Pursuance of approval from relevant agencies of a medical pilot program and gathering support from Congressional leaders. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES 40000   0 0 2017-10-17T14:43:00.983000-04:00
2027585 STANFORD UNIVERSITY 690283f7-caeb-45a4-9320-ccb68fd8cdd4 Q3 STANFORD UNIVERSITY 36492 STANFORD UNIVERSITY 2017 third_quarter MED Affordable Care Act Reform Health Professions Programs Graduate Medical Education Funding Pediatric GME Programs Precision Medicine Initiative Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE   90000 0 0 2017-10-17T14:59:45.923000-04:00
2027615 SQUIRE PATTON BOGGS 2ad30626-6027-46a1-9936-2097581d571c Q3 SQUIRE PATTON BOGGS 30906 THOMAS JEFFERSON UNIVERSITY 2017 third_quarter MED Advancing health system legislative and regulatory issues including: programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program; and expand access to specialized health care through telehealth. SENATE 60000   0 0 2017-10-17T15:07:07.127000-04:00
2027660 SQUIRE PATTON BOGGS 6b61df6c-cb73-467b-a1b5-217aedb49c1c Q3 SQUIRE PATTON BOGGS 30906 UNIVERSITY OF GEORGIA 2017 third_quarter MED Traumatic brain injury research, funding, and outreach opportunities. Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES 40000   0 0 2017-10-17T15:14:34.673000-04:00
2028071 HOGAN LOVELLS US LLP 8adfc6ac-7d2e-43c0-8bf2-11f8866cef49 Q3 HOGAN LOVELLS US LLP 18422 COLDCHAIN TECHNOLOGY SERVICES 2017 third_quarter MED Pursuing opportunities for better logistical application for storage and delivery of vaccines. Commerce, Dept of (DOC),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2017-10-17T16:27:35.853000-04:00
2028193 MICHAEL N. MCCARTY LAW OFFICE PLLC 1dc56a40-e676-4c44-a37d-af05d845712e Q3 MICHAEL N. MCCARTY LAW OFFICE PLLC 401104300 AMERICAN MEDICAL TECHNOLOGISTS 2017 third_quarter MED Regulation of Laboratory Developed Tests; Funding for harmonization of diagnostic test results; House and Senate legislation to repeal and replace or amend the Affordable Care Act, particularly as such legislation may affect access to clinical laboratory services. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2017-10-17T17:12:05.797000-04:00
2028384 PODESTA GROUP, INC. a2172cfb-f58e-47a1-9784-6dd7521f7550 3T PODESTA GROUP, INC. 31680 HUMAN LONGEVITY, INC. 2017 third_quarter MED Healthcare and biotechnology. Genetic non-discrimination. Regulation of diagnostic tests. HOUSE OF REPRESENTATIVES,SENATE 40000   0 1 2017-10-17T18:41:45.720000-04:00
2028484 HOGAN LOVELLS US LLP dfeb5bfd-0a90-4a02-beaa-88afdbfd19bd 3A HOGAN LOVELLS US LLP 18422 HEARTFLOW, INC. 2017 third_quarter MED Medicare payment issues Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2017-10-17T22:44:10.093000-04:00
2028637 THE CJR GROUP, INC. 0bc31222-af3a-4324-9616-72ff2118b79f Q3 THE CJR GROUP, INC. 288293 UNIVERSITY HOSPITALS HEALTH SYSTEM 2017 third_quarter MED Issues impacting hospitals HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2017-10-18T09:25:12.793000-04:00
2028816 WILLIAMS AND JENSEN, PLLC ac7d7cea-fd84-4181-957b-ac5ac2fa692f Q3 WILLIAMS AND JENSEN, PLLC 41454 MT PHARMA AMERICA, INC. 2017 third_quarter MED Matters affecting access to and pricing of pharmaceuticals; matters affecting the Orphan Drug Act. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2017-10-18T10:10:59.813000-04:00
2028938 CORNERSTONE GOVERNMENT AFFAIRS, INC. 629f73e5-feb9-436d-99de-1d9103134c5e Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 CHILDREN'S NATIONAL MEDICAL CENTER 2017 third_quarter MED Representation on health-related issues including reimbursement, research, public-health & clinical care Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 50000   0 0 2017-10-18T10:30:12.283000-04:00
2029027 CHILDREN'S HOSPITAL AND HEALTH SYSTEM, INC. 40c18051-800a-4550-b19e-b3eb728539b3 Q3 CHILDREN'S HOSPITAL AND HEALTH SYSTEM, INC. 401103415 CHILDREN'S HOSPITAL AND HEALTH SYSTEM, INC. 2017 third_quarter MED Implementation of the 21st Century Cures Act, provisions related to pediatric training and research. Establishment of a pediatric program office or coordinating council at the National Institutes of Health HOUSE OF REPRESENTATIVES,SENATE   130000 0 0 2017-10-18T10:40:06.147000-04:00
2029041 CORNERSTONE GOVERNMENT AFFAIRS, INC. 0c68780a-4660-4c45-9427-795c6d2d98d7 Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 CITY OF HOPE MEDICAL CENTER 2017 third_quarter MED Medicare/Medicaid reimbursement, clinical research HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2017-10-18T10:43:15.410000-04:00
2029131 PUBLIC SPHERE, INC. ddfb4466-9294-4939-8c61-970a91812ca8 Q3 PUBLIC SPHERE, INC. 401104153 SI-BONE 2017 third_quarter MED General company overview for members and staff. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2017-10-18T10:51:59.897000-04:00
2029134 FAEGRE DRINKER BIDDLE & REATH LLP 76004405-efe7-417c-bd9a-ec814215fc03 Q3 FAEGRE DRINKER BIDDLE & REATH LLP 12631 PREECLAMPSIA FOUNDATION 2017 third_quarter MED Preeclampsia Research Issues. HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2017-10-18T10:52:03.147000-04:00
2029155 NATIONAL ENVIRONMENTAL HEALTH ASSOCIATION d83d8954-c063-4869-baac-0647f9524e77 Q3 NATIONAL ENVIRONMENTAL HEALTH ASSOCIATION 401103538 NATIONAL ENVIRONMENTAL HEALTH ASSOCIATION 2017 third_quarter MED Increase funding for labs for Zika research HOUSE OF REPRESENTATIVES,SENATE     0 0 2017-10-18T10:55:14.087000-04:00
2029213 HOGAN LOVELLS US LLP 724a2b7e-3325-4276-b4cb-2f4929e82cf1 Q3 HOGAN LOVELLS US LLP 18422 SPECIALISTS ON CALL 2017 third_quarter MED Identifying telemedicine opportunities in the federal contracting areas. HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) 20000   0 0 2017-10-18T11:11:53.663000-04:00
2029548 BRACEWELL LLP 26455ce7-e571-4b96-b536-4b71b0b6e4aa Q3 BRACEWELL LLP 6837 AIR LIQUIDE USA LLC 2017 third_quarter MED Work related to medical gases Bureau of Land Management (BLM),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),Internal Revenue Service (IRS),SENATE,Treasury, Dept of 60000   0 0 2017-10-18T12:10:34.857000-04:00
2029649 EFB ADVOCACY, LLC 349b9609-956a-4b75-91d7-3c73b285e762 3T EFB ADVOCACY, LLC 401104430 QGA PUBLIC AFFAIRS ON BEHALF OF UNITED FOR MEDICAL RESEARCH 2017 third_quarter MED Funding issues related to the National Institutes of Health HOUSE OF REPRESENTATIVES,SENATE 31500   0 1 2017-10-18T12:32:24.093000-04:00
2029717 OREGON HEALTH & SCIENCE UNIVERSITY 91609100-a51d-4291-af2f-bb96763730d8 Q3 OREGON HEALTH & SCIENCE UNIVERSITY 30291 OREGON HEALTH & SCIENCE UNIVERSITY 2017 third_quarter MED Impact of Budget Control Act of 2011's Sequestration on medical research; use of animals in biomedical research; moving medical research from bench to bedside more quickly including greater sharing of research data, reducing administrative burden on medical researchers, streamline of clinical trials, increased flexibility in the FDAs approval process for drugs and devices tied with additional review in post-market: "21st Century Cures Act" (H.R. 34); FDA regulation of mitochondrial replacement therapy Sections 736 in "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017" (H.R. 5054/S. 2956); importance of research using fetal tissue; importance of Small Business Innovation Research and Small Technology Transfer Research program; FDA regulation of laboratory developed test. HOUSE OF REPRESENTATIVES,SENATE   70000 0 0 2017-10-18T12:58:05.970000-04:00
2029732 CAPITOL HILL STRATEGIES, LLC 3c0bebff-d6dc-49f8-bd06-b8a4284fb93b Q3 CAPITOL HILL STRATEGIES, LLC 91774 BIOGEN INC 2017 third_quarter MED Issues dealing with newborn screening. H.R. 2430, the FDA Reauthorization Act (FDARA) of 2017, legislation to reauthorize the Prescription Drug User Fee Act (PDUFA), as reauthorized by the Food and Drug Administration Safety and Innovation Act of 2012 (FDASIA). Issues dealing with Alzheimer's treatments HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2017-10-18T13:01:48.367000-04:00
2029947 MWW GROUP b7cc8526-1670-4542-a62a-82f82b725c8f Q3 MWW GROUP 26318 NORTHEAST OHIO UNIVERSITIES COLLEGES OF MEDICINE AND PHARMACY (NEOMED) 2017 third_quarter MED Research and funding opportunities in general and for newly discovered mechanisms and tests for human testing, including for listeria and Zika; STEM-M school and STEM education opportunities Defense, Dept of (DOD),Education, Dept of,Justice, Dept of (DOJ),Natl Institutes of Health (NIH) 10000   0 0 2017-10-18T14:04:12.087000-04:00
2029960 SPINA BIFIDA ASSOCIATION OF AMERICA 071e63f6-f797-46f9-af18-669d341951e0 Q3 SPINA BIFIDA ASSOCIATION OF AMERICA 46665 SPINA BIFIDA ASSOCIATION OF AMERICA 2017 third_quarter MED Activities to support the Spina Bifida community and research relating to all people affected by Spina Bifida Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   12821 0 0 2017-10-18T14:04:14.510000-04:00
2030003 MWW GROUP faf207cf-9ee2-4dee-946a-8d6067f38d29 Q3 MWW GROUP 26318 THOMAS JEFFERSON UNIVERSITY AND HEALTH SYSTEM 2017 third_quarter MED NCI designated cancer centers program; Computational Biology; Funding for NIH Specialized Programs of Research Excellence (SPORE) grants; Health disparities research; Regional Clinical Trial networks; Telestroke/telehealth/telemedicine programs; Global programs; Campus visits on research Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE,State, Dept of (DOS) 40000   0 0 2017-10-18T14:08:34.480000-04:00
2030108 LOCKRIDGE, GRINDAL, NAUEN, PLLP 2b6fdb03-1777-4fbe-8452-2352a261dbe8 Q3 LOCKRIDGE, GRINDAL, NAUEN, PLLP 23053 HENNEPIN COUNTY MEDICAL CENTER 2017 third_quarter MED FY2018 Authorizations, Appropriations, and Budget Policy HOUSE OF REPRESENTATIVES,SENATE     0 0 2017-10-18T14:26:30.577000-04:00
2030261 THE CORMAC GROUP, LLC 639e53cc-1137-4d4f-bbed-beb315cb86d9 Q3 THE CORMAC GROUP, LLC 66773 KESSLER FOUNDATION 2017 third_quarter MED Appropriations, DOD, TBI Research, Veterans Issues HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2017-10-18T14:50:06.453000-04:00
2030462 CATHOLIC HEALTH ASSOCIATION OF THE UNITED STATES 1818a38a-0a42-4b20-bcca-725f754cfd43 Q3 CATHOLIC HEALTH ASSOCIATION OF THE UNITED STATES 8497 CATHOLIC HEALTH ASSOCIATION OF THE UNITED STATES 2017 third_quarter MED Supported the creation of additional ICD-10-CM medical diagnosis codes to account for human trafficking victims in clinical settings. Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   190000 0 0 2017-10-18T15:09:08.517000-04:00
2030475 INDIANA CHAMBER OF COMMERCE, INC. d5e9d15f-5867-4ee2-8179-d56de6019c5d Q3 INDIANA CHAMBER OF COMMERCE, INC. 19263 INDIANA CHAMBER OF COMMERCE INC 2017 third_quarter MED Health Care Reform Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,SENATE   40000 0 0 2017-10-18T15:16:18.627000-04:00
2030559 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. daf9548d-178f-44fc-b407-672df209086d Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ASSOCIATION FOR MOLECULAR PATHOLOGY 2017 third_quarter MED Regulation of laboratory diagnostics No bill number, Diagnostic Accuracy and Innovation Act Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2017-10-18T15:31:21.520000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 2611.11ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API